US 10059771
Methods for treating nasal polyposis by administering an IL-4R antagonist
granted A61KA61K2039/505A61K31/135
Quick answer
US patent 10059771 (Methods for treating nasal polyposis by administering an IL-4R antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 57
- CPC classes
- A61K, A61K2039/505, A61K31/135, A61K31/136, A61K31/137